Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 3/2018

01-09-2018 | Original Research

Patterns of Presentation, Treatment, and Survival Rates of Gallbladder Cancer: a Prospective Study at a Tertiary Care Centre

Authors: Santosh Kumar Singh, Rajnish Talwar, Narayanan Kannan, Arvind Kumar Tyagi, Pradeep Jaiswal, Adarsh Kumar

Published in: Journal of Gastrointestinal Cancer | Issue 3/2018

Login to get access

Abstract

Background

India has high incidence of gallbladder carcinoma with regional variation in incidence, the highest in Northern India. This study examines the patterns of presentation, treatment strategies, and survival rate of all patients with gallbladder cancer (GBC) evaluated at our tertiary academic hospital over a period of 2 years.

Methods

All patients presented to our institute with established tissue diagnosis of carcinoma gallbladder were accrued in our study over a time period of 2 years. Presentation, treatment modalities, and survival rates were analyzed.

Results

One hundred six patients were included: 80 females and 26 males (F: M = 3:1). Median age was 60 years. Eighty patients (75%) had gallstones and 20 patients (21%) had typical history of chronic cholecystitis. The common symptom and sign at presentation were pain in the right upper abdomen (81%) and lump abdomen (49%), respectively. Overall resectability rate was 19.8% (21/106). Eighty-five patients were unresectable or metastatic and treated with palliative intent. Stagewise distribution at diagnosis was stage I (0%), stage II (4%), stage IIIA (10%), stage IIIB (8%), stage IVA (17%), and stage IVB (61%). Estimated 1-year survival for stages II, IIIA, IIIB, IVA, and IVB was 100, 76, 47.4, 26, and 10.6%, respectively. Significant difference in OS was observed among different stages of GBC (p value <0.001).

Conclusion

If proper investigations are done, radical surgery including multi-organ resection can be curative with acceptable morbidity and mortality. Stage at presentation and ability to perform curative resection are the most important prognostic factors predicting survival. Palliative chemotherapy should be considered for metastatic GBC.
Literature
1.
go back to reference Indian Council of Medical Research. National cancer registry programme. Biennial report 1988–89. An epidemiological study. New Delhi: Indian Council of Medical Research; 1992. p. 14–5. Indian Council of Medical Research. National cancer registry programme. Biennial report 1988–89. An epidemiological study. New Delhi: Indian Council of Medical Research; 1992. p. 14–5.
2.
go back to reference Dixon E, Vollmer Jr CM, Sahajpal A, et al. An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center. Ann Surg. 2005;241:385–94.CrossRefPubMedPubMedCentral Dixon E, Vollmer Jr CM, Sahajpal A, et al. An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center. Ann Surg. 2005;241:385–94.CrossRefPubMedPubMedCentral
3.
go back to reference Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg. 2000;232:557–69.CrossRefPubMedPubMedCentral Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg. 2000;232:557–69.CrossRefPubMedPubMedCentral
4.
go back to reference Bartlett DL, Fong Y, Fortner JG, et al. Long-term results after resection for gallbladder cancer: implications for staging and management. Ann Surg. 1996;224:639–46.CrossRefPubMedPubMedCentral Bartlett DL, Fong Y, Fortner JG, et al. Long-term results after resection for gallbladder cancer: implications for staging and management. Ann Surg. 1996;224:639–46.CrossRefPubMedPubMedCentral
5.
go back to reference Tyagi BB, Manoharan N, Raina V. Risk factors for gallbladder cancer: a population based case-control study in Delhi. Indian J Med Paediatr Oncol. 2008;29:16–26.CrossRef Tyagi BB, Manoharan N, Raina V. Risk factors for gallbladder cancer: a population based case-control study in Delhi. Indian J Med Paediatr Oncol. 2008;29:16–26.CrossRef
6.
go back to reference Matsukura N, Yokomuro S, Yamada S, et al. Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract. Jpn J Cancer Res. 2002;93:842.CrossRefPubMedPubMedCentral Matsukura N, Yokomuro S, Yamada S, et al. Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract. Jpn J Cancer Res. 2002;93:842.CrossRefPubMedPubMedCentral
7.
go back to reference Kondo S, Nimura Y, Kamiya J, et al. Mode of tumor spread and surgical strategy in gallbladder carcinoma. Langenbeck's Arch Surg. 2002;387:222–8.CrossRef Kondo S, Nimura Y, Kamiya J, et al. Mode of tumor spread and surgical strategy in gallbladder carcinoma. Langenbeck's Arch Surg. 2002;387:222–8.CrossRef
8.
go back to reference Hueman MT, Vollmer Jr CM, Pawlik TM. Evolving treatment strategies for gallbladder cancer. Ann Surg Oncol. 2009;16:2101–15.CrossRefPubMed Hueman MT, Vollmer Jr CM, Pawlik TM. Evolving treatment strategies for gallbladder cancer. Ann Surg Oncol. 2009;16:2101–15.CrossRefPubMed
9.
go back to reference Pitt HA, Nakeeb A. Operative approach to gallbladder cancer. Curr Gastroenterol Rep. 2006;8:161–7.CrossRefPubMed Pitt HA, Nakeeb A. Operative approach to gallbladder cancer. Curr Gastroenterol Rep. 2006;8:161–7.CrossRefPubMed
10.
go back to reference de Aretxabala X, Roa I, Berrios M, Hepp J, Gallardo J, Cordova A, Roa JC, Leon J, Maluenda F. Chemoradiotherapy in gallbladder cancer. J Surg Oncol. 2006;93:699–704.CrossRefPubMed de Aretxabala X, Roa I, Berrios M, Hepp J, Gallardo J, Cordova A, Roa JC, Leon J, Maluenda F. Chemoradiotherapy in gallbladder cancer. J Surg Oncol. 2006;93:699–704.CrossRefPubMed
11.
go back to reference Amano H, Takada T, Matsushiro, T Nimura Y, Nagakawa T, Nakayama T, Gomi K. Five-year results of a randomized study of postoperative adjuvant chemotherapy for resected pancreatic-biliary carcinomas. ASCO Meeting 1999. Amano H, Takada T, Matsushiro, T Nimura Y, Nagakawa T, Nakayama T, Gomi K. Five-year results of a randomized study of postoperative adjuvant chemotherapy for resected pancreatic-biliary carcinomas. ASCO Meeting 1999.
12.
go back to reference Gallardo JO, Rubio B, Fodor M, Orlandi L, Yanez M, Gamargo C, Ahumada M. A phase II study of gemcitabine in gallbladder carcinoma. Ann Oncol. 2001;12:1403–6.CrossRefPubMed Gallardo JO, Rubio B, Fodor M, Orlandi L, Yanez M, Gamargo C, Ahumada M. A phase II study of gemcitabine in gallbladder carcinoma. Ann Oncol. 2001;12:1403–6.CrossRefPubMed
13.
go back to reference Doval DC, Sekhon JS, Gupta SK, Fuloria J, Shukla VK, Gupta S, Awasthy BS. A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer. Br J Cancer. 2004;90:1516–20.CrossRefPubMedPubMedCentral Doval DC, Sekhon JS, Gupta SK, Fuloria J, Shukla VK, Gupta S, Awasthy BS. A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer. Br J Cancer. 2004;90:1516–20.CrossRefPubMedPubMedCentral
14.
go back to reference Sharma A, Dwary AD, Mohanti BK, Deo SV, Pal S, Sreenivas V, Raina V, Shukla NK, Thulkar S, Garg P, Chaudhary SP. Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study. J Clin Oncol. 28:4581–6. Sharma A, Dwary AD, Mohanti BK, Deo SV, Pal S, Sreenivas V, Raina V, Shukla NK, Thulkar S, Garg P, Chaudhary SP. Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study. J Clin Oncol. 28:4581–6.
15.
go back to reference Glimelius B, Hoffman K, Sjoden PO, et al. Chemotherapy improves survival and quality of life in pancreatic and biliary tract cancer. Ann Oncol. 1996;7:593–600.CrossRefPubMed Glimelius B, Hoffman K, Sjoden PO, et al. Chemotherapy improves survival and quality of life in pancreatic and biliary tract cancer. Ann Oncol. 1996;7:593–600.CrossRefPubMed
16.
go back to reference Mekeel KL, Hemming AW. Surgical management of gallbladder carcinoma: a review. J Gastrointest Surg. 2007;11:1188–93.CrossRefPubMed Mekeel KL, Hemming AW. Surgical management of gallbladder carcinoma: a review. J Gastrointest Surg. 2007;11:1188–93.CrossRefPubMed
17.
go back to reference Randi G, Franceschi S, La VC. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118:1591.CrossRefPubMed Randi G, Franceschi S, La VC. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118:1591.CrossRefPubMed
18.
go back to reference Diehl AK. Epidemiology of gallbladder cancer: a synthesis of recent data. J Natl Cancer Inst. 1980;65:1209–14.PubMed Diehl AK. Epidemiology of gallbladder cancer: a synthesis of recent data. J Natl Cancer Inst. 1980;65:1209–14.PubMed
20.
go back to reference Principe A, Del Gaudio M, Ercoloni G, Golfieri R, Cucchetti A, Pinna AD. Radical surgery for gallbladder carcinoma: possibilities of survival. Hepato-Gastroenterology. 2006;53(71):660–4.PubMed Principe A, Del Gaudio M, Ercoloni G, Golfieri R, Cucchetti A, Pinna AD. Radical surgery for gallbladder carcinoma: possibilities of survival. Hepato-Gastroenterology. 2006;53(71):660–4.PubMed
21.
go back to reference Reid KM, Ramos-De la Medina A, Donohue JH. Diagnosis and surgical management of gallbladder cancer: a review. J Gastrointest Surg. 2007;11:671–81.CrossRefPubMed Reid KM, Ramos-De la Medina A, Donohue JH. Diagnosis and surgical management of gallbladder cancer: a review. J Gastrointest Surg. 2007;11:671–81.CrossRefPubMed
22.
go back to reference Pandey M, Shukla VK. Diet and gallbladder cancer: a case-control study. Eur J Cancer Prev. 2002;11:365–8.CrossRefPubMed Pandey M, Shukla VK. Diet and gallbladder cancer: a case-control study. Eur J Cancer Prev. 2002;11:365–8.CrossRefPubMed
23.
go back to reference Moerman CJ, Bueno de Mesquita HB, Smeets FW, Runia S. Lifestyle factors including diet and cancer of the gallbladder and bile duct: a population-based case-control study in The Netherlands. Eur J Cancer Prev. 1997;6:139–42.PubMed Moerman CJ, Bueno de Mesquita HB, Smeets FW, Runia S. Lifestyle factors including diet and cancer of the gallbladder and bile duct: a population-based case-control study in The Netherlands. Eur J Cancer Prev. 1997;6:139–42.PubMed
24.
go back to reference Taner CB, Nagorney DM, Donohue JH. Surgical treatment of gallbladder cancer. J Gastrointest Surg. 2004;8:83–9. discussion 89CrossRefPubMed Taner CB, Nagorney DM, Donohue JH. Surgical treatment of gallbladder cancer. J Gastrointest Surg. 2004;8:83–9. discussion 89CrossRefPubMed
25.
go back to reference Zhang BH, Yi B, Peng LH, Zhang BH, Jiang XQ, Wu MC. The relationship between surgery and prognosis of gallbladder carcinoma. Hepatobiliary Pancreat Dis Int. 2003;2(4):581–6.PubMed Zhang BH, Yi B, Peng LH, Zhang BH, Jiang XQ, Wu MC. The relationship between surgery and prognosis of gallbladder carcinoma. Hepatobiliary Pancreat Dis Int. 2003;2(4):581–6.PubMed
26.
go back to reference DeMatteo RP, Wagman R, Blumgart LH, Fong Y. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer. 2003;98:1689–700.CrossRefPubMed DeMatteo RP, Wagman R, Blumgart LH, Fong Y. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer. 2003;98:1689–700.CrossRefPubMed
27.
28.
go back to reference Gold DG, Miller RC, Haddock MG, Gunderson LL, Quevedo F, Donohue JH, Bhatia S, Nagorney DM. Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys. 2009;75:150–5.CrossRefPubMed Gold DG, Miller RC, Haddock MG, Gunderson LL, Quevedo F, Donohue JH, Bhatia S, Nagorney DM. Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys. 2009;75:150–5.CrossRefPubMed
29.
go back to reference Kim S, Kim SW, Bang YJ, Heo DS, Ha SW. Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys. 2002;54:414–9.CrossRefPubMed Kim S, Kim SW, Bang YJ, Heo DS, Ha SW. Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys. 2002;54:414–9.CrossRefPubMed
30.
go back to reference Park HS, Lim JY, Yoon DS, Park JS, Lee DK, Lee SJ, et al. Outcome of adjuvant therapy for gallbladder cancer. Oncology. 2010;79:168–73.CrossRefPubMed Park HS, Lim JY, Yoon DS, Park JS, Lee DK, Lee SJ, et al. Outcome of adjuvant therapy for gallbladder cancer. Oncology. 2010;79:168–73.CrossRefPubMed
32.
go back to reference Todoroki T, Takahashi H, Koike N, et al. Outcomes of aggressive treatment of stage IV gallbladder cancer and predictors of survival. Hepato-Gastroenterology. 1999;46:2114–21.PubMed Todoroki T, Takahashi H, Koike N, et al. Outcomes of aggressive treatment of stage IV gallbladder cancer and predictors of survival. Hepato-Gastroenterology. 1999;46:2114–21.PubMed
33.
go back to reference Meng H, Wang X, Fong Y, Wang Z-H, Yu W, Zhang Z-T. Outcomes of radical surgery for gallbladder cancer patients with lymphatic metastases. Jpn J Clin Oncol. 2011;41(8):992–8.CrossRefPubMed Meng H, Wang X, Fong Y, Wang Z-H, Yu W, Zhang Z-T. Outcomes of radical surgery for gallbladder cancer patients with lymphatic metastases. Jpn J Clin Oncol. 2011;41(8):992–8.CrossRefPubMed
Metadata
Title
Patterns of Presentation, Treatment, and Survival Rates of Gallbladder Cancer: a Prospective Study at a Tertiary Care Centre
Authors
Santosh Kumar Singh
Rajnish Talwar
Narayanan Kannan
Arvind Kumar Tyagi
Pradeep Jaiswal
Adarsh Kumar
Publication date
01-09-2018
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 3/2018
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-017-9940-y

Other articles of this Issue 3/2018

Journal of Gastrointestinal Cancer 3/2018 Go to the issue